These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 31118805)

  • 21. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
    Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
    Front Oncol; 2020; 10():769. PubMed ID: 32582536
    [No Abstract]   [Full Text] [Related]  

  • 22. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
    Wu X; Zhang X; Tao L; Dai X; Chen P
    Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cancer Genome Atlas (TCGA) based m
    Liu J; Sun G; Pan S; Qin M; Ouyang R; Li Z; Huang J
    Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mettl3-m6A-YTHDF1 axis promotion of mitochondrial dysfunction in metabolic dysfunction-associated steatotic liver disease.
    Wang S; Zhang W; Wang Z; Liu Z; Yi X; Wu J
    Cell Signal; 2024 Sep; 121():111303. PubMed ID: 39019337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 27. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
    Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L
    Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
    Chang X; Lv YF; He J; Cao Y; Li CQ; Guo QN
    J Hepatocell Carcinoma; 2021; 8():85-101. PubMed ID: 33738268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
    Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma.
    Nakagawa N; Sonohara F; Tanaka K; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Oncol Lett; 2021 Jul; 22(1):538. PubMed ID: 34084217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of m6A reader YTHDF2 prognosis, immune infiltration, and related regulatory networks in hepatocellular carcinoma.
    Wang H; Cai H; Li L
    Heliyon; 2024 Jan; 10(1):e23204. PubMed ID: 38163150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.
    Liu X; Qin J; Gao T; Li C; He B; Pan B; Xu X; Chen X; Zeng K; Xu M; Zhu C; Pan Y; Sun H; Sun L; Xu T; Wang S
    Mol Ther Nucleic Acids; 2020 Dec; 22():750-765. PubMed ID: 33230473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhao X; Chen Y; Mao Q; Jiang X; Jiang W; Chen J; Xu W; Zhong L; Sun X
    Cancer Biomark; 2018; 21(4):859-868. PubMed ID: 29439311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J; Xu L; Pan H
    Front Oncol; 2020; 10():1444. PubMed ID: 32974164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.